NCT05130775

Measurement of Tricuspid Regurgitation Volume for Assessment of Tricuspid Regurgitation Using 3D Transesophageal Echocardiography

Name: Clinical Trial NCT05130775
Creator: Tufts Medical Center
Keywords: Tricuspid Regurgitation, Transesophageal echocardiograpgy, other, clinical trial, United States of America

Tufts Medical Center·ClinicalTrials.gov·otherRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Tricuspid Regurgitation
Drug/Device/Intervention: Transesophageal echocardiograpgy
Study type: Observational
Intervention type: other

Sponsor & location

Primary sponsor: Tufts Medical Center
Location: Boston, United States of America

Timeline & enrollment

Phase: N/A
Start date: Aug 22, 2022
End date: Jul 15, 2023
Enrollment: 60 participants

Primary outcome

Tricuspid regurgitation volume

Summary

This study is a prospective observational chart review. The aim of the study is to evaluate tricuspid regurgitation volume using 3D volumetric assessment as an accurate method for tricuspid regurgitation severity in comparison to VCA.

ICD-10 classifications

Tricuspid stenosisTricuspid stenosis with insufficiencyNonrheumatic tricuspid (valve) stenosisTricuspid insufficiencyNonrheumatic tricuspid (valve) stenosis with insufficiency

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05130775
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05130775 through Pure Global AI's free database. This phase not specified trial is sponsored by Tufts Medical Center and is currently Recruiting. The study focuses on Tricuspid Regurgitation. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.